EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 199 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,029,000 | -4.0% | 30,350 | -17.8% | 0.40% | +15.8% |
| Q1 2017 | $1,072,000 | -37.6% | 36,912 | -32.3% | 0.35% | -15.5% |
| Q3 2016 | $1,719,000 | +309.3% | 54,512 | +264.8% | 0.41% | +435.1% |
| Q2 2016 | $420,000 | -56.7% | 14,945 | -44.0% | 0.08% | -45.0% |
| Q1 2016 | $970,000 | -87.7% | 26,686 | -86.4% | 0.14% | -83.5% |
| Q4 2015 | $7,855,000 | +281.7% | 196,322 | +171.8% | 0.85% | +327.3% |
| Q3 2015 | $2,058,000 | +503.5% | 72,241 | +598.7% | 0.20% | +500.0% |
| Q2 2015 | $341,000 | -92.1% | 10,340 | -93.1% | 0.03% | -92.2% |
| Q1 2015 | $4,294,000 | +18.3% | 149,318 | +12.0% | 0.42% | +21.7% |
| Q4 2014 | $3,631,000 | +296.4% | 133,355 | +210.3% | 0.35% | +338.0% |
| Q3 2014 | $916,000 | +4.8% | 42,981 | +24.3% | 0.08% | +36.2% |
| Q1 2014 | $874,000 | -56.2% | 34,575 | -60.2% | 0.06% | -38.3% |
| Q4 2013 | $1,996,000 | -7.7% | 86,799 | -23.6% | 0.09% | -5.1% |
| Q3 2013 | $2,163,000 | +42.6% | 113,546 | +7.9% | 0.10% | +54.7% |
| Q2 2013 | $1,517,000 | – | 105,198 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |